SYNTHENA
Synthena is a development stage biotechnology company aiming to develop and commercialize new life saving drugs for the treatment of severe neuromuscular diseases based on the modulation of RNA. Its proprietary tricyclo-DNA technology platform offers broad advantages over state of the art oligonucleotide chemistries for new RNA intervention strategies like splice switching, and other antisense approaches. Its most advanced preclinical drug development program focuses on Duchenne Muscular Dystrophy, a genetic disorder which affects 1/3,500 boys and which leads to death in early adulthood.
SYNTHENA
Industry:
Biotechnology Health Care Medical
Address:
Bern, Bern, Switzerland
Country:
Switzerland
Website Url:
http://www.synthena.com
Status:
Closed
Contact:
+41(0) 31 631 4265
Email Addresses:
[email protected]
Technology used in webpage:
Font Awesome United Domains
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
G2 Therapies
G2 is a privately funded biotechnology company that develops and commercializes novel antibody-based therapies in inflammation and cancer.
Genome
Genome is a biotechnology company developing and commercializing DNA sequencing technology.
SIRENADE Pharmaceuticals
A drug development start-up company that uses an integrated system of molecular tools to develop novel small molecule inhibitors.
Spirogen
Spirogen is a clinical stage biotechnology company specialising in novel, sequence-selective, DNA minor groove-binding molecules with
Official Site Inspections
http://www.synthena.com
- Host name: cluster021.hosting.ovh.net
- IP address: 188.165.53.185
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
